Correlation Between Cardiff Oncology and Madrigal Pharmaceuticals
Can any of the company-specific risk be diversified away by investing in both Cardiff Oncology and Madrigal Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Cardiff Oncology and Madrigal Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Cardiff Oncology and Madrigal Pharmaceuticals, you can compare the effects of market volatilities on Cardiff Oncology and Madrigal Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Cardiff Oncology with a short position of Madrigal Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Cardiff Oncology and Madrigal Pharmaceuticals.
Diversification Opportunities for Cardiff Oncology and Madrigal Pharmaceuticals
0.38 | Correlation Coefficient |
Weak diversification
The 3 months correlation between Cardiff and Madrigal is 0.38. Overlapping area represents the amount of risk that can be diversified away by holding Cardiff Oncology and Madrigal Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Madrigal Pharmaceuticals and Cardiff Oncology is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Cardiff Oncology are associated (or correlated) with Madrigal Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Madrigal Pharmaceuticals has no effect on the direction of Cardiff Oncology i.e., Cardiff Oncology and Madrigal Pharmaceuticals go up and down completely randomly.
Pair Corralation between Cardiff Oncology and Madrigal Pharmaceuticals
Given the investment horizon of 90 days Cardiff Oncology is expected to generate 1.69 times more return on investment than Madrigal Pharmaceuticals. However, Cardiff Oncology is 1.69 times more volatile than Madrigal Pharmaceuticals. It trades about 0.07 of its potential returns per unit of risk. Madrigal Pharmaceuticals is currently generating about 0.06 per unit of risk. If you would invest 128.00 in Cardiff Oncology on September 4, 2024 and sell it today you would earn a total of 131.00 from holding Cardiff Oncology or generate 102.34% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Very Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Cardiff Oncology vs. Madrigal Pharmaceuticals
Performance |
| Timeline |
| Cardiff Oncology |
| Madrigal Pharmaceuticals |
Cardiff Oncology and Madrigal Pharmaceuticals Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Cardiff Oncology and Madrigal Pharmaceuticals
The main advantage of trading using opposite Cardiff Oncology and Madrigal Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Cardiff Oncology position performs unexpectedly, Madrigal Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Madrigal Pharmaceuticals will offset losses from the drop in Madrigal Pharmaceuticals' long position.| Cardiff Oncology vs. Reviva Pharmaceuticals Holdings | Cardiff Oncology vs. PDS Biotechnology Corp | Cardiff Oncology vs. Reviva Pharmaceuticals Holdings | Cardiff Oncology vs. Eyenovia |
| Madrigal Pharmaceuticals vs. TG Therapeutics | Madrigal Pharmaceuticals vs. Terns Pharmaceuticals | Madrigal Pharmaceuticals vs. Hepion Pharmaceuticals | Madrigal Pharmaceuticals vs. Viking Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio File Import module to quickly import all of your third-party portfolios from your local drive in csv format.
Other Complementary Tools
| Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
| Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
| Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon | |
| ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments | |
| Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges |